ViruSure launches pioneering first-in-class viral contamination test for biopharmaceuticals using Oxford Nanopore technology
New adventitious viral agent (AVA) detection test offers rapid, sensitive, and affordable viral screening for biomanufacturers OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–#Lifesciences–ViruSure, a global leader in pathogen safety testing for biopharmaceuticals, and Oxford Nanopore Technologies (“Oxford Nanopore”) (LSE: ONT), the company behind a new generation of molecular sensing technology based on nanopores, today announce the … [Read more…]